MADD anticorps
Aperçu rapide pour MADD anticorps (ABIN7466967)
Antigène
Voir toutes MADD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Souris
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the center region of mouse MADD. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: Neuro2A , Raw264.7
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.39 mg/mL
-
Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- MADD (MAP-Kinase Activating Death Domain (MADD))
-
Autre désignation
- MAP-kinase activating death domain
-
Sujet
- MAP-kinase activating death domain , 9630059K23Rik , IG20,Plays a significant role in regulating cell proliferation, survival and death through alternative mRNA splicing. Converts GDP-bound inactive form of RAB3A, RAB3C and RAB3D to the GTP-bound active forms. Component of the TNFRSF1A signaling complex: MADD links TNFRSF1A with MAP kinase activation. Plays an important regulatory role in physiological cell death (TNF-alpha-induced, caspase-mediated apoptosis).
-
Poids moléculaire
- 175 kDa
-
ID gène
- 228355
-
UniProt
- Q80U28
-
Pathways
- Caspase Cascade in Apoptosis
Antigène
-